SCM
GSK icon

Silverarc Capital Management’s GSK GSK Stock Holding History

Silverarc Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-136,178
Closed -$4.79M – 90
2022
Q4 		$4.79M Buy
+136,178
New +$4.54M 1.37% 26

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Silverarc Capital Management's GSK Position: Q1 2023 in Review

Silverarc Capital Management sold out of GSK (GSK) in Q1 2023, closing a stake of 136,178 shares — an estimated $4.79M sold.

Silverarc Capital Management first reported a position in GSK in Q4 2022 and held it in 1 quarter. The position peaked at $4.79M in Q4 2022. 808 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • Silverarc Capital Management reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 136,178 GSK shares in Q1 2023, an estimated $4.79M.
  • Silverarc Capital Management first reported a position in GSK in Q4 2022 and held it in 1 quarter.
  • Silverarc Capital Management's GSK position peaked at $4.79M in Q4 2022.
  • 808 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Silverarc Capital Management's 13F filing for Q1 2023, filed 15 May 2023.